Overview Financials News + Filings Key Docs Charts Ownership Insiders |
SCIENTIFIC INDUSTRIES INC (SCND)
|
Add to portfolio |
|
|
Price: |
$6.05
| | Metrics |
OS: |
7
|
M
| |
|
|
Market cap: |
$42.4
|
M
| |
|
|
Net cash:
|
$644.5
|
k
| |
$0.09
|
per share
|
EV:
|
$41.7
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
Revenues | 11.4 | 9.8 | 7.8 | 10.2 | 8.5 | 8.1 | 9.6 | 7.8 |
Revenue growth | 16.6% | 25.6% | -23.7% | 20.3% | 4.1% | -15.1% | 22.3% | 15.5% |
Cost of goods sold | 5.7 | 4.8 | 3.8 | 5.8 | 5.3 | 5.3 | 5.7 | 4.7 |
Gross profit | 5.7 | 5.0 | 3.9 | 4.4 | 3.2 | 2.9 | 3.9 | 3.1 |
Gross margin | 50.3% | 50.9% | 50.6% | 42.8% | 38.0% | 35.3% | 40.8% | 39.8% |
Sales and marketing | 4.3 | 4.0 | 1.2 | 1.1 | 1.0 | 0.9 | 1.4 | 1.0 |
Research and development | 2.9 | 1.6 | 1.1 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 |
General and administrative | 5.8 | 4.0 | 2.3 | 1.9 | 1.7 | 1.7 | 1.7 | 1.7 |
EBIT | -7.3 | -4.7 | -0.7 | 0.8 | 0.0 | -0.1 | 0.5 | 0.0 |
EBIT margin | -63.7% | -48.2% | -8.5% | 7.6% | -0.1% | -1.4% | 4.8% | -0.2% |
Pre-tax income | -7.0 | -4.1 | -0.7 | 0.8 | 0.0 | -0.1 | 0.2 | 0.0 |
Income taxes | -1.3 | -1.2 | -0.4 | 0.1 | 0.2 | -0.1 | 0.1 | 0.0 |
Tax rate | 19.3% | 28.4% | 65.4% | 16.2% | 11564.3% | 50.5% | 24.3% | 219.2% |
Earnings from continuing ops | -5.6 | -3.1 | -0.5 | 0.6 | -0.2 | -0.1 | 0.2 | 0.0 |
Earnings from discontinued ops | | -0.6 | -0.2 | | | | | |
Net income | -5.6 | -3.7 | -0.7 | 0.6 | -0.2 | -0.1 | 0.2 | 0.0 |
Net margin | -49.5% | -37.6% | -9.0% | 6.3% | -1.9% | -0.9% | 1.7% | 0.1% |
|
Diluted EPS | ($0.85) | ($0.98) | ($0.30) | $0.43 | ($0.11) | ($0.05) | $0.11 | $0.01 |
Shares outstanding (diluted) | 6.6 | 3.2 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|